NCT02499874View on ClinicalTrials.gov

SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected Women

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 5, 2017

Study Completion Date

October 5, 2017

Conditions
HIV
Interventions
DRUG

Efavirenz

oral Efavirenz 400mg

DRUG

tenofovir /emtricitabine

tenofovir 245 mg/emtricitabine 200mg

DRUG

tenofovir/lamivudine

tenofovir 245mg/lamivudine 300mg

DRUG

lamivudine/zidovudine

lamivudine 300mg/zidovudine 600mg

Trial Locations (1)

Unknown

St Stephen's Centre, Chelsea and Westminster Hospital, London

Sponsors

Collaborators (1)

Mylan Inc.
All Listed Sponsors
collaborator

Mylan Inc.

INDUSTRY

lead

St Stephens Aids Trust

OTHER